|
|
blood coagulation
|
GO:0007596 |
76 |
0.682
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.614
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.608
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.527
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.475
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.454
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.439
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.437
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.435
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.421
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.418
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.414
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.397
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.397
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.372
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.371
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.365
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.348
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.320
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.319
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.307
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.296
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.291
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.290
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.283
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.281
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.280
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.278
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.250
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.245
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.239
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.239
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.222
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.219
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.214
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.211
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.208
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.204
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.200
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.198
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.194
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.193
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.184
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.183
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.183
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.178
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.176
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.176
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.172
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.169
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.164
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.161
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.159
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.159
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.158
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.155
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.155
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.151
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.151
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.150
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.150
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.150
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.148
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.146
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.145
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.144
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.143
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.143
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.142
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.141
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.141
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.139
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.139
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.137
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.135
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.132
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.131
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.126
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.123
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.122
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.120
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.120
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.119
|
|
|
|
cellular magnesium ion homeostasis
|
GO:0010961 |
3 |
0.119
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.118
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.117
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.115
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.114
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.113
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.113
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.112
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.111
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.108
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.106
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.106
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.105
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.105
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.105
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.104
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.104
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.102
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.102
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.102
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.101
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.100
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.100
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.099
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.099
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.099
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.097
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.096
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.096
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.096
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.095
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.095
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.094
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.094
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.093
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.093
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.092
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.092
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.092
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.090
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.090
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.090
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.089
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.088
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.088
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.088
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.088
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.087
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.087
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.087
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.087
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.087
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.086
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.086
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.086
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.085
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.085
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.084
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.083
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.082
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.082
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.082
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.081
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.081
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.081
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.080
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.080
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.079
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.079
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.079
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.079
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.078
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.078
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.078
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.078
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.078
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.077
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.077
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.076
|
|
|
|
lung secretory cell differentiation
|
GO:0061140 |
13 |
0.076
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.076
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.076
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.075
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.075
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.074
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.073
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.073
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.073
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.072
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.072
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.071
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.071
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.071
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.070
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.070
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.069
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.069
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.069
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.068
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.068
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.067
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.066
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.066
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.066
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.065
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.064
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.064
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.064
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.063
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.063
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.063
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.063
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.063
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.063
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.062
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.062
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.062
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.062
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.061
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.061
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.061
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.061
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.060
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.060
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.059
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.059
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.059
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.059
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.059
|
|
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.058
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.058
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.058
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.058
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.058
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.058
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.057
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.057
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.057
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.057
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.057
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.056
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.056
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.056
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.055
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.055
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.055
|
|
|
|
t cell migration
|
GO:0072678 |
19 |
0.055
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.055
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.055
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.054
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.054
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.054
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.054
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.053
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.053
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.053
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.053
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.052
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.052
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.052
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.052
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.052
|
|
|
|
defense response to nematode
|
GO:0002215 |
4 |
0.052
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.051
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.051
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.051
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.051
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.051
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.051
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.051
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.051
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.051
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.051
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.050
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.050
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.050
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.050
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.050
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.049
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.049
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.049
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.049
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.049
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.049
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.049
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.049
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.049
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.048
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.048
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.048
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.047
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.046
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.046
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.046
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.046
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.046
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.046
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.046
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.045
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.045
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.045
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.045
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.045
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.044
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.044
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.044
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.044
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.044
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.044
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.044
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.044
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.044
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.043
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.043
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.043
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.043
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.043
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.043
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.043
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.043
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.043
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.042
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.042
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.042
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.042
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.042
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.042
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.042
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.042
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.042
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.041
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.041
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.041
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.041
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.041
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.041
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.041
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.041
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.041
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.041
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.041
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.041
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.040
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.039
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.039
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.039
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.039
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.039
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.039
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.039
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.039
|
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.038
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.038
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.038
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.038
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.037
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.037
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.037
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.037
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.037
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.037
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.037
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.037
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.037
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.037
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.037
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.037
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.037
|
|
|
|
ammonium transmembrane transport
|
GO:0072488 |
2 |
0.037
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.037
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.037
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.037
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.037
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.036
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.036
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.036
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.036
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.036
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.036
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.036
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.036
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.036
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.036
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.036
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.035
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.035
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.035
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.035
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.035
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.035
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.035
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.035
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.035
|
|
|
|
regulation of stress fiber assembly
|
GO:0051492 |
15 |
0.034
|
|
|
|
citrulline biosynthetic process
|
GO:0019240 |
2 |
0.034
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.034
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.034
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.034
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.034
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.034
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.034
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.034
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.034
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.034
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.034
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.034
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.034
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.033
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.033
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.033
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.033
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.033
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.033
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.033
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.033
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.033
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.033
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.033
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.033
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.033
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.033
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.033
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.033
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.032
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.032
|
|
|
|
negative regulation of t cell mediated immunity
|
GO:0002710 |
9 |
0.032
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.032
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.032
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.032
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.032
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.032
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.032
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.032
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.031
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.031
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.031
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.031
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.031
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.031
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.031
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.031
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.031
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.030
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.030
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.030
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.030
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.030
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.030
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.030
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.030
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.030
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.030
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.030
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.030
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.030
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.030
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.030
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.030
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.030
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.029
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.029
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.029
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.029
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.029
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.029
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.029
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.029
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.029
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.029
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.029
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.029
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.029
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.029
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.029
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.029
|
|
|
|
regulation of eosinophil degranulation
|
GO:0043309 |
1 |
0.028
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.028
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.028
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.028
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.028
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.028
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.028
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.028
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.028
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.028
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.028
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.028
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.028
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.027
|
|
